glp-1 medications covered by insurance What Is Prior Authorization for GLP-1s? Poll: 1 in 8 Adults

Thanks to biochemical engineering, the glucagon-like peptide-1 (GLP-1) molecule has emerged as an

Only 40% of 2023 initiators remained on therapy after a year compared to 34% of 2022 initiators and 33% of 2021 initiators

Analysis of nearly 8,000 adults found 45% keep the weight off after one year

Among 28,953 NAE reports associated with GLP-1 RAs, 19 distinct NAE signals were identified using reporting odds ratios (RORs), including dizziness, tremor, dysgeusia, lethargy, taste disorder, presyncope, parosmia, allodynia, and hypoglycemic unconsciousness, etc

Berberine patches reviewed: what science says about effectiveness, how they compare to oral supplements, side effects, and safety guidance.